Cibc World Market Inc. reduced its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 63.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 73,107 shares of the real estate investment trust's stock after selling 126,193 shares during the quarter. Cibc World Market Inc.'s holdings in Healthpeak Properties were worth $1,564,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. OneDigital Investment Advisors LLC increased its stake in Healthpeak Properties by 3.3% in the second quarter. OneDigital Investment Advisors LLC now owns 15,376 shares of the real estate investment trust's stock valued at $329,000 after purchasing an additional 493 shares during the last quarter. Clearstead Trust LLC grew its holdings in shares of Healthpeak Properties by 66.7% during the 2nd quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust's stock worth $29,000 after purchasing an additional 543 shares during the period. CX Institutional grew its holdings in shares of Healthpeak Properties by 6.1% during the 2nd quarter. CX Institutional now owns 11,003 shares of the real estate investment trust's stock worth $235,000 after purchasing an additional 633 shares during the period. Fiduciary Trust Co increased its position in Healthpeak Properties by 4.9% during the 3rd quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust's stock worth $264,000 after purchasing an additional 644 shares in the last quarter. Finally, Quadrant Capital Group LLC raised its holdings in Healthpeak Properties by 1.9% in the third quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust's stock valued at $721,000 after buying an additional 718 shares during the period. Institutional investors and hedge funds own 93.57% of the company's stock.
Healthpeak Properties Stock Performance
Healthpeak Properties stock opened at $21.23 on Friday. The firm has a market capitalization of $14.64 billion, a PE ratio of 60.67, a price-to-earnings-growth ratio of 2.35 and a beta of 1.01. Healthpeak Properties, Inc. has a one year low of $15.70 and a one year high of $22.95. The stock's 50 day moving average price is $21.52 and its 200 day moving average price is $19.17. The company has a debt-to-equity ratio of 1.06, a quick ratio of 3.02 and a current ratio of 3.02.
Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.05. The company had revenue of $771.58 million during the quarter, compared to the consensus estimate of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. Healthpeak Properties's revenue for the quarter was up 11.1% on a year-over-year basis. During the same quarter last year, the company earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, sell-side analysts expect that Healthpeak Properties, Inc. will post 1.77 EPS for the current fiscal year.
Healthpeak Properties Dividend Announcement
The company also recently declared a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 5.7%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties's dividend payout ratio (DPR) is presently 348.57%.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on DOC. BMO Capital Markets lifted their price target on shares of Healthpeak Properties from $20.00 to $24.00 and gave the company an "outperform" rating in a research report on Monday, June 15th. Wells Fargo & Company raised their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company an "equal weight" rating in a research note on Wednesday, July 15th. Cantor Fitzgerald raised their target price on shares of Healthpeak Properties from $20.00 to $23.00 and gave the company a "neutral" rating in a research note on Thursday, August 6th. Morgan Stanley restated an "equal weight" rating and set a $22.00 target price (up from $20.00) on shares of Healthpeak Properties in a report on Thursday, June 11th. Finally, Robert W. Baird increased their price target on Healthpeak Properties from $21.00 to $24.00 and gave the company an "outperform" rating in a report on Thursday, August 13th. Four equities research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $21.66.
Check Out Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Recommended Stories
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.